Category: biotech

.China’s Duplicity Biotherapeutics has submitted (PDF) paperwork for a Hong Kong IPO, looking for a confidential sum to power an extensive pipeline of antibody-drug conjugates

.Though Alkeus Pharmaceuticals’ dental eye disease asset neglected to considerably decrease geographic atrophy (GA) lesion development, the biotech is pointing out “medically purposeful” outcomes and

.While the biotech investment scene in Europe has actually decreased quite following a COVID-19 financing boom in 2021, a brand-new file from PitchBook advises financial

.Merck &amp Co. has actually promptly redeemed a few of the prices of its Harpoon Therapies acquistion, drawing in $170 thousand ahead of time through

.Cullinan Therapy was actually thrilled enough along with Port BioMed’s bispecific immune reactor that it turned over $25 million in 2013 for the medicine’s united

.Welcome to this week’s Chutes &amp Ladders, our roundup of substantial management hirings, shootings and also retirings across the industry. Please send the praise– or

.Compass Pathways’ trip to period 3 experimental anxiety records is actually taking much longer than counted on. Along with the tests overwhelming by months, the

.Vertex has actually reported phase 3 records on its own near-approval ache medication applicant suzetrigine, shedding light on how the non-opioid painkiller incorporates along with

.Cognition Therapeutics’ stage 2 sparkle test has actually taken several of the appeal off the Alzheimer’s illness drug applicant CT1812. The oral sigma-2 antagonist stopped

.Welcome to recently’s Chutes &amp Ladders, our summary of considerable leadership hirings, firings and also retirings throughout the sector. Feel free to send out the